Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma
- PMID: 23825782
- PMCID: PMC3698250
- DOI: 10.3978/j.issn.2072-1439.2012.10.08
Pulmonary tumor thrombotic microangiopathy from metastatic epithelioid angiosarcoma
Abstract
The lung is most common site for metastatic disease via hematogenous route. Tumor emboli of the vessels of the lung induces fibrocellular and fibromuscular intimal proliferation. These histopathological changes may cause pulmonary tumor trombotic microangiopaty. Few cases are diagnosed antemortem. We report a 60 year old woman with by metastatic epithelioid angiosarcoma involving the lung. Tumor cells were positive for VEGF and topoisomerase II. VEGF may be involved in the pathogenesis pulmonary tumor trombotic microangioapy and topoisomerase II positivity showed sensitivity against catalytic topoisomerase II inhibitors.
Keywords: Angiosarcoma; Pulmonary tumor thrombotic microangiopathy; Topoisomerase II; Vascular endothelial growth factor.
Figures








References
-
- Corrin B, Nicholson AG. Pathology of the Lungs, pp682, third ed, Elsevier, China, 2011.
-
- Yao DX, Flieder DB, Hoda SA. Pulmonary tumor thrombotic microangiopathy. An often missed antemortem diagnosis. Arch Pathol Lab Med 2001;125:304-5 - PubMed
-
- Chinen K, Fujino T, Horita A, et al. Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and vascular endothelial growth factor. Pathol Res Pract 2009;205:63-8 - PubMed
-
- Fletcher CD, Beham A, Bekir S, et al. Epithelioid angiosrcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol 1991;15:915-24 - PubMed
Publication types
LinkOut - more resources
Full Text Sources